Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion type Assertion NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_head.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion description "[GEP100 was expressed in 70% of primary breast ductal carcinomas, and was preferentially co-expressed with EGFR in the malignant cases.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_provenance.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion evidence source_evidence_literature NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_provenance.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion SIO_000772 18084281 NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_provenance.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion wasDerivedFrom befree-20140225 NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_provenance.
- NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_assertion wasGeneratedBy ECO_0000203 NP806529.RAA6ZqlRoQGWJU2o0q_U1kvrHUpG0NW57f86J4lNDxdCM130_provenance.